United States · FDA National Drug Code directory

BUSPIRONE HYDROCHLORIDE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-2081_a764c113-34fb-4f9d-837b-ac8c53488b2f
Product NDC
71335-2081
Form
TABLET
Composition / generic term
BUSPIRONE HYDROCHLORIDE
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20200221
Source listing expiry
20261231

Source-listed ingredients

  • BUSPIRONE HYDROCHLORIDE — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BOTTLE (71335-2081-1) · 71335-2081-1
  • 60 TABLET in 1 BOTTLE (71335-2081-2) · 71335-2081-2
  • 90 TABLET in 1 BOTTLE (71335-2081-3) · 71335-2081-3
  • 45 TABLET in 1 BOTTLE (71335-2081-4) · 71335-2081-4
  • 180 TABLET in 1 BOTTLE (71335-2081-5) · 71335-2081-5
  • 120 TABLET in 1 BOTTLE (71335-2081-6) · 71335-2081-6

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →